Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31 results about "Beta-Hydroxybutyric acid" patented technology

Β-Hydroxybutyric acid, also known as 3-hydroxybutyric acid, is an organic compound and a beta hydroxy acid with the chemical formula CH₃CH(OH)CH₂CO₂H; its conjugate base is β-hydroxybutyrate, also known as 3-hydroxybutyrate. β-Hydroxybutyric acid is a chiral compound with two enantiomers: D-β-hydroxybutyric acid and L-β-hydroxybutyric acid. Its oxidized and polymeric derivatives occur widely in nature. In humans, D-β-hydroxybutyric acid is one of two primary endogenous agonists of hydroxycarboxylic acid receptor 2 (HCA₂), a Gᵢ⸝ₒ-coupled G protein-coupled receptor (GPCR).

Liquid stable kit for measuring beta-hydroxybutyric acid by cyclic enzyme method

The invention discloses a liquid stable kit for measuring beta-hydroxybutyric acid by a cyclic enzyme method. The liquid stable kit consists of a reagent 1 and a reagent 2, wherein 1L of reagent 1 comprises 50 to 500mmol of buffer solution, 1 to 5KU of beta-hydroxybutyrate dehydrogenase, 1 to 5KU of diaphorase, 0.1 to 100g of surfactant, 1 to 100mmol of stabilizer, 0.1 to 100g of anti-interference agent I, 0.1 to 100g of anti-interference agent II, and 0.1 to 100ml of preservative; and 1L of reagent 2 comprises 50 to 500mmol of buffer solution, 1 to 20mmol of coenzyme I, 0.1 to 10mmol of nitrotetrazolium blue, 1 to 100mmol of stabilizer and 0.1 to 100ml of preservative. The liquid stable kit has the advantages of stability, wide linear range, high measurement accuracy, high antijamming capability and low cost.
Owner:NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO LTD

Postpartum dairy cow drenching nutritious supplementary and application method thereof

InactiveCN103340317AEffective maintenance levelLower levelAnimal feeding stuffDiseaseBeta-Hydroxybutyric acid
The invention discloses a postpartum new dairy cow drenching nutritious supplementary and application thereof in a nutritious supplementary for treating postpartum hypocalcemia, abomasum displacement or ketosis disease of dairy cow. The nutritious supplementary provided by the invention is capable of effectively maintaining the levels of blood calcium, blood magnesium and glucose and reducing the levels of NEFA (Non-Esterified Fatty Acid) and beta-hydroxybutyric acid, thereby effectively reducing the occurrence rate of metabolic diseases of postpartum paralysis, ketosis, abomasum displacement and the like of new dairy cow. As a result, the dairy cow can be rehabilitated in physical power and food intake quickly, and the health condition of the dairy cow can be improved and the milk yield of the dairy cow can be increased; and good economic benefit can be achieved.
Owner:CHANGCHUN BORUI FEED

Kit for detecting urinary lactic acid, creatine and beta-hydroxybutyric acid in human urine simultaneously

The invention provides a kit for detecting urinary lactic acid, creatine and beta-hydroxybutyric acid of human urine simultaneously, comprising a urine purification unit and a dry chemical reaction unit, wherein the urine purification unit is provided with a selective absorbent with combination of neutral alumina and activated carbon in weight ratio of 0.2-1:0.1-2, wherein the activated carbon is soaked by sodium hydroxide with concentration of 10-20%, and the selective absorbent is baked in a closed in a drying oven at the temperature of 70-250 DEG C for 4-72h; and the dry chemical reaction unit is a reaction box with a urinary lactic acid detection hole, a creatine detection hole and a beta-hydroxybutyric acid detection hole. The invention can detect concentration of urinary lactic acid, creatine and beta-hydroxybutyric acid of human urine simultaneously quickly and easily without help of other instruments and professional personnel so as to obtain qualitative or semiquantitative results.
Owner:北京中生金域诊断技术股份有限公司

Method for measuring beta-hydroxybutyric acid by using enzyme colorimetric reaction, matched kit and application thereof

The invention provides a method for measuring beta-hydroxybutyric acid by using enzyme colorimetric reaction, a matched kit and application thereof. Under the system of Tris-HCL buffer solution, serum beta-hydroxybutyric acid and coenzyme I are dehydrogenized under the catalysis of beta-hydroxybutyric acid dehydrogenase to generate acetoacetic acid and reduced coenzyme I, the generated reduced coenzyme I and iodonitrotetrazole chloride are reacted under the catalysis of diaphorase to generate a red substance formazane of which the highest absorbance is 505 nanometers, and then the content of the beta-hydroxybutyric acid in a biological sample is quantified by measuring the change of the absorbance of the red product at the wavelength of 505 nanometers. The method can linearly measure the concentration range (0 to 4.5 mmol / L) of the beta-hydroxybutyric acid in the biological sample, the measurement is used for judging the human ketosis for acid poisoning diagnosis, the reagent used by the method is liquid dual-reagent, and the quantity of the sample required for measuring the beta-hydroxybutyric acid is little; moreover, the reaction time during measuring is short, the operation is simple, and the method is suitable for mass detection.
Owner:NINGBO RUI BIO TECH

Stabilized beta-hydroxybutyric acid detection test paper and preparation method thereof

The invention relates to stabilized beta-hydroxybutyric acid detection test paper and a preparation process thereof. The stabilized beta-hydroxybutyric acid detection test paper consists of a whole blood filter layer, a developing layer and a base layer which are sequentially stacked, wherein the whole blood filter layer is formed by combining at least one polymer film layer; the developing layer is made of a hydrophilic material; and the base layer is made of an insoluble supportive material. The method for preparing the stabilized beta-hydroxybutyric acid detection test paper comprises the following steps of: a, soaking the developing layer into reagent solution for 2 hours, taking the soaked developing layer out, and drying the soaked developing layer by cold air; and b, cutting the whole blood filter layer, the soaked and dried developing layer and the base layer into the same specifications, and sequentially bonding the layers with glue from top to bottom. The test paper is not limited by conditions such as region and the like; patients can conveniently perform self-monitor at any time and at any place; the concentration of beta-hydroxybutyric acid can be detected in a short time by only using micro blood; and the test paper is simple to prepare and has wide market value.
Owner:苏州市玮琪生物科技有限公司

Synthesis of degradable poly-beta-oxybate

The method for synthesizing completely-degradable plastics poly beta-hydroxybutyrate includes the folloiwng steps: adopting acetaldehyde as raw material to prepare beta-hydroxybutanal; oxidizing it to prepare beta-hydroxybutyric acid; esterifying it to prepare ethyl beta-hydroxybutyrate and polymerizing it to prepare poly beta-hydroxybutyrate. It is characterized by that preparation of beta-hydroxybutanal adopts benzene as solvent, sodium hydroxide as catalyst, its reaction temp. is 1-15 deg.C and the organic acid is used as neutralizing reagent, the preparation of beta-hydroxybutyric acid adopts ethyl acetate as solvent, cobalt acetate as catalyst, its reaction temp. is 40-100 deg.c and reaction pressure is 0.3-1.5 MPa, the preparation of ethyl ebeta-hydroxybutyrate adopts cresulsulfonicacid as catalyst and ethyl alcohol as solvent and polymerization preparation of beta-hydroxybutyrate uses isopropyl titanate as catalyst.
Owner:BIOLOGY INST OF SHANDONG ACAD OF SCI +1

Self-catalysis fast curing type pure polyester resin as well as preparation method and application thereof

The invention belongs to the technical field of powdery paint, and particularly relates to self-catalysis fast curing type pure polyester resin, and further discloses a preparation method of the elf-catalysis fast curing type pure polyester resin and a purpose of the elf-catalysis fast curing type pure polyester resin for preparing outdoor TGIC powder paint. The self-catalysis fast curing type pure polyester resin is prepared by using terephthalic acid, 1,4-naphthalic acid, trimethyl-1,6-hexanediol, neopentyl glycol, 1,2,4-butanediol, gamma-trimethylamine-beta-hydroxybutyric acid, N,N,N-trimethyl-2-hydroxyhexadecyl ammonium chloride and glycol bis(2-aminoethyl ether) tetraacethyl as raw materials through polymerization. The self-catalysis performance of the polyester resin is prominent; the curing activity is high; under the condition without additionally adding a curing accelerant, the fast curing with a curing agent TGIC can be realized. A curing membrane prepared by the self-catalysis fast curing type pure polyester resin has excellent performance; the performance in all aspects better reaches the use requirements of outdoor pure polyester resin.
Owner:黄山市向荣新材料有限公司

Composition containing L-carnitine and beta-hydroxybutyric acid compounds

The invention provides a composition containing L-carnitine and a beta-hydroxybutyric acid compound, and specifically provides a composition containing the L-carnitine and at least one beta-hydroxybutyric acid compound. The beta-hydroxybutyric acid compound comprises beta-hydroxybutyrate, a beta-hydroxybutyric acid precursor or a combination thereof; and preferably, the L-carnitine and beta-hydroxybutyric acid amino acid exist in the composition in a form of intramolecular salt. The invention furthermore provides a preparation method of the L-carnitine-beta-hydroxybutyrate. The composition provided by the invention is high in stability, high in bioavailability and significant in weight loss effect and ketogenic effect; and the preparation method provided by the invention is easy and convenient to operate.
Owner:BRIGHTGENE BIO MEDICAL TECH (SUZHOU) CO LTD

Biodegradable peanut protein plastic with long service life

The invention discloses a biodegradable peanut protein plastic with a long service life. The biodegradable peanut protein plastic comprises the following raw material in parts by weight: 30 to 35 parts of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) PHBV, 55 to 60 parts of modified-beta-hydroxybutyric acid, 15 to 20 parts of peanut protein powder, 15 to 18 parts of nano cellulose whiskers, 3 t o 5 parts of amylase, 1.1 to 1.3 parts of a silane coupling agent KH590, 2 to 3 parts of sodium lactate, 0.5 to 0.8 parts of sodium dehydroacetate, 1.7 t o 2.3 parts of dioctyl terephthalate DOTP, 2 to 4 parts of octyl epoxy stearate, 25 to 28 parts of carbon black N550, 12 to 16 parts of ground calcium carbonate, 4 to 7 parts of kaolin, 10 to 12 parts of hard pottery clay, and 0.7 to 0.9 parts of an antioxidant. The peanut protein plastic can be biologically degraded into low molecular compound, is high in flexility, good in impact resistance and oxidation resistance, low in water absorption, and low in complete degradation velocity, and the service life of the biodegradable peanut protein plastic can be prolonged.
Owner:广东一龙新材料科技有限公司

Marker group for diagnosing and distinguishing coronary arterial atherosclerosis from stable angina pectoris

The invention discloses a marker group for diagnosing and distinguishing coronary arterial atherosclerosis from stable angina pectoris. The marker group comprises one or more of glutathione, beta-hydroxybutyric acid, proline, fumaric acid, phenylalanine and lactic acid. When a single marker is used for diagnosing and distinguishing patients with the stable angina pectoris from patients with the coronary arterial atherosclerosis, the AUCs (areas under curve) of a ROC (receiver operating characteristic) are all 0.7 or larger, and the marker has a clinical diagnosis significance; when the markers are used for diagnosis in combination, with the increase of the combination number, the AUC is further increased and reaches 0.988 when 6 markers are combined, and the sensitivity and the specificity are 98.5% and 98.3% respectively under the optimum cutoff value. The metabolic marker group can accurately diagnose and distinguish the coronary arterial atherosclerosis from the stable angina pectoris, and is high in sensitivity and specificity.
Owner:CHINA PHARM UNIV

Method for preparing test paper for rapidly determining dairy cows subclinical ketosis

The invention discloses a method for preparing a test paper for rapidly determining dairy cows subclinical ketosis, which comprises the following steps of: adding boric acid, aminoacetic acid and ethylene diamine tetraacetic acid solution in Arabic gum dissolved in a hot-water bath, adjusting the pH value of the prepared solution to be 7.0, soaking the test paper for 20 minutes in the prepared solution while the prepared solution is hot, drying the test paper in a drying oven at 60 DEG C, and standing the test paper in the drying oven overnight; and dissolving ethylene glycol, sodium nitroprusside and absolute ethyl alcohol in the hot-water bath, soaking the test paper for 20 minutes in the prepared solution while the prepared solution is hot, taking the test paper out, blotting moisture in the test paper by using filter paper, drying the test paper in the drying oven at 60 DEG C, and standing the test paper in the drying oven overnight so as to obtain the test paper. The reagent strip takes the concentration of beta-hydroxybutyric acid in blood more than 1.2mmol / L as a positive criteria; and the production practice proves that the reagent strip has the advantages of low cost, simple and easy operation, quick response, high specificity and high sensitivity, can be used for various determined samples such as blood, urine, serum, plasma and milk, and has wide application scope.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Antifouling and wear-resisting textile material and preparation method thereof

The invention discloses an antifouling and wear-resisting textile material and a preparation method thereof. The antifouling and wear-resisting textile material is prepared from the following raw materials in parts by weight: 10 to 25 parts of acrylonitrile fibers, 12 to 25 parts of carboxymethyl cellulose, 2 to 10 parts of nano-microcrystalline cellulose, 10 to 20 parts of bamboo charcoal fibers, 11 to 28 parts of diglycidyl ether, 3 to 5 parts of lauryl alcohol, 1 to 3 parts of bis-(phenyldimethyl siloxane)methylsilanol, 4 to 6 parts of beta-hydroxybutyrate, 1 to 3 parts of sodium thiosulfate pentahydrate, 8 to 14 parts of terephthaloyl chloride, 3 to 7 parts of fluorosilane, 1 to 4 parts of methyl L-pyroglutamate, 2 to 3 parts of benzoyl peroxide butyl acetate, 3 to 5 parts of 2,2'-(ethylenedioxy)dianiline, 1 to 2 parts of zinc diricinoleate, 1 to 2 parts of barium metaborate, 2 to 5 parts of an adhesive, 2 to 5 parts of a dispersant and 1 to 4 parts of a thermal stabilizer. The antifouling and wear-resisting textile material prepared by the preparation method has good wear-resisting performance and also has an antifouling property. Meanwhile, the invention further discloses the preparation method of the antifouling and wear-resisting textile material.
Owner:SUZHOU COMFORT TEXTILE NEW MATERIALS TECH CO LTD

Application of beta-hydroxybutyric acid or pharmaceutically acceptable salt thereof

ActiveCN104940181AImprove pathological functional changesImprove diabetesMetabolism disorderAntinoxious agentsDiseaseBeta-Hydroxybutyric acid
The invention discloses application of a beta-hydroxybutyric acid or a pharmaceutically acceptable salt thereof, particularly discloses application of a beta-hydroxybutyric acid or a pharmaceutically acceptable salt thereof in preparation of medicines for preventing and treating diabetes mellitus and chronic complication thereof, and belongs to the technical field of medicines. A diabetes rat model is induced with streptozotocin (STZ); the prevention and treatment effects of the beta-hydroxybutyric acid on diabetes and chronic complication of rats are observed with the beta-hydroxybutyric acid through subcutaneous injection; the result shows that the weight loss of the rats can be restrained by the beta-hydroxybutyric acid; the pathology function change of chronic pancreas, great vessels, kidneys, hearts, livers and the like of the rats is improved; the beta-hydroxybutyric acid or the pharmaceutically acceptable salt thereof as an active pharmaceutical ingredient is combined with conventional additives in the field of medicines to prepare medicines; the beta-hydroxybutyric acid or the pharmaceutically acceptable salt thereof can be used for improving the diabetes and the chronic complication thereof; and clinical treatment is carried out by aiming at diseases caused by anti-oxidative stress and nitration injuries.
Owner:ZHUKANG BIOTECHNOLOGY CO LTD

Liquid stable kit for measuring beta-hydroxybutyric acid by cyclic enzyme method

The invention discloses a liquid stable kit for measuring beta-hydroxybutyric acid by a cyclic enzyme method. The liquid stable kit consists of a reagent 1 and a reagent 2, wherein 1L of reagent 1 comprises 50 to 500mmol of buffer solution, 1 to 5KU of beta-hydroxybutyrate dehydrogenase, 1 to 5KU of diaphorase, 0.1 to 100g of surfactant, 1 to 100mmol of stabilizer, 0.1 to 100g of anti-interference agent I, 0.1 to 100g of anti-interference agent II, and 0.1 to 100ml of preservative; and 1L of reagent 2 comprises 50 to 500mmol of buffer solution, 1 to 20mmol of coenzyme I, 0.1 to 10mmol of nitrotetrazolium blue, 1 to 100mmol of stabilizer and 0.1 to 100ml of preservative. The liquid stable kit has the advantages of stability, wide linear range, high measurement accuracy, high antijamming capability and low cost.
Owner:NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO LTD

Perfusion agent for preventing and treating postpartum hypocalcemia and ketosis of dairy cows

The invention relates to a perfusion agent for preventing and treating postpartum hypocalcemia and ketosis of dairy cows. The perfusion agent is prepared from the following components in parts by mass: 400-500 parts of a calcium supplement from different sources, 100-200 parts of an energy metabolism regulator, 50-100 parts of a magnesium supplement and the balance of a carrier. The perfusion agent can effectively raise the blood level of the dairy cows and prevent or treat the hypocalcemia through postpartum perfusion; lipid mobilization of the dairy cows is relieved, blood beta-hydroxybutyric acid and free fatty acid are reduced, and the ketosis is prevented; abomasum displacement is prevented; the milk yield of the dairy cows is increased, the early lactation elimination rate is reduced, and good application prospect is achieved.
Owner:上海健荷牧业科技有限公司

Health-care granules for preventing negative balance of energy metabolism of cows and using method of health-care granules

The invention discloses health-care granules for preventing the negative balance of energy metabolism of cows and a using method of the health-care granules. The health-care granules disclosed by the invention are mainly prepared from the following raw materials: calcium propionate, brown sugar, magnesium chloride, yeast, sodium chloride and corn flour. The health-care granules for feeding the cows, disclosed by the invention, have the advantages of being convenient to use, low in cost, good in palatability, notable in effects and the like. After the postnatal cows are fed with the health-care granules, physical strength can be quickly restored, the quantity of rumen microbial populations can be maintained, the food consumption is restored, the milk yield is increased, and the ability of resisting diseases is improved. Feeding experiments for the postnatal cows confirm that the health-care granules can effectively maintain the level of blood calcium (Ga), serum phosphate (P), blood magnesium (Mg) and blood sugar (GLU), and can reduce the level of beta-hydroxybutyric acid (BHBA), free fatty acid (NEFA), and aspartate aminotransferase (AST). The attack rate of nutrient metabolic disease-ketosis of the postnatal cows can be effectively reduced.
Owner:HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY

Ultraviolet-proof and biodegradable packaging film

The invention provides an ultraviolet-proof and biodegradable packaging film. The packaging film comprises a biodegradable ultraviolet reflecting layer and a photodegradable ultraviolet absorbing layer, wherein the biodegradable ultraviolet reflecting layer is prepared from a poly(beta-hydroxybutyric acid)-beta-hydroxypentanoic acid copolymer, aluminum powder, lubricant paraffin, a calcium-zinc compound stabilizer and maleic anhydride, and the photodegradable ultraviolet absorbing layer is prepared from an ethylene-carbon monoxide copolymer, an anti-ultraviolet mixture, titanium dioxide and the lubricant paraffin, wherein the thickness ratio of the biodegradable ultraviolet reflecting layer to the photodegradable ultraviolet absorbing layer is 1:(1-3), and the thickness of the photodegradable ultraviolet absorbing layer ranges from 0.005mm-0.12mm. The ultraviolet-proof and biodegradable packaging film is capable of rejecting more than 90% of ultraviolet, has excellent mechanical and physical properties, and can be degraded 100% without any pollution on the environment.
Owner:大连华诺塑胶科技有限公司

Application of betulinic acid in promotion of fatty-acid oxidation

The invention discloses application of betulinic acid in promotion of fatty-acid oxidation and particularly relates to the application of betulinic acid in preparation of medicines for preventing or treating related diseases of fatty-acid oxidation. The application disclosed by the invention has the beneficial effects that a fat C57 mouse with high-fat feeding for modeling is adopted as a researchobject, and the experimental result shows that the gene levels of the high-fat mouse treated by betulinic acid and the fatty-acid oxidation are respectively and obviously increased in different tissues, and the content of beta-hydroxybutyric acid (beta-OHB) in serum is also increased, i.e., betulinic acid can promote fatty-acid oxidation. Meanwhile, the body weight of the high-fat mouse treated by betulinic acid is obviously reduced; the application provides actual evidence of betulinic acid for treating obesity, non-alcoholic fatty liver disease (NAFLD) and other diseases related to the fatty-acid oxidation, has important scientific value and medical significance, and meanwhile can provide precious experiences for developing more natural-medicine active components for treating related diseases by promoting the fatty-acid oxidation.
Owner:SHANGHAI INST FOR ENDOCRINE & METABOLIC DISEASES

Environmentally friendly antibacterial plastic film and preparation technology thereof

The invention discloses an environmentally friendly antibacterial plastic film, which comprises a film matrix and an antibacterial layer covered on the surface of one side of the film matrix. The filmmatrix is prepared from following raw materials in parts by weight: 60 to 70 parts of polyethylene, 20 to 30 parts of poly(beta-hydroxybutyric acid), 3 to 4 parts of modified bamboo powder, 5 to 8 parts of polyethylene wax, 2 to 3 parts of iron stearate, 1 to 2 parts of an antioxidant, and 1 to 2 parts of a plasticizer. The antibacterial layer is formed by painting an antibacterial liquid on thesurface of the film matrix. The invention further discloses a preparation technology of the plastic film. Polyethylene and poly(beta-hydroxybutyric acid) are taken as the film matrix; under the actionof iron stearate, poly(beta-hydroxybutyric acid) can effectively exert the biodegradation performance and a photo degradation performance; then modified bamboo powder is added to enhance the mechanical properties and strength; the antibacterial liquid is painted on the surface of the film matrix to form the antibacterial layer, which has an excellent antibacterial performance, at the same time, the binding force between the antibacterial layer and the film matrix is also enhanced; and the integrity of the plastic film is improved.
Owner:安徽超星新材料科技有限公司

Environmentally-friendly degradable packaging paper

InactiveCN109385057AReduce water absorption strengthHigh affinityFlexible coversWrappersPolyethylene glycolNitrogen gas
The invention discloses environmentally-friendly degradable packaging paper, the raw materials of which include, by weight, 100-120 parts of kraft paper, 40-60 parts of polylactic acid, 4-8 parts of modified microspheres, 2-8 parts of poly(beta-hydroxybutyric acid), 4-6 parts of polyethylene, 40-60 parts of a filling supplement agent, 1-2 parts of a titanate coupling agent, 2-4 parts of sodium alginate, 4-8 parts of a plasticizer, and 1.5-2.5 parts of an UV531 anti-UV agent. The filling supplement agent includes bamboo fiber, precipitated barium sulfate, sepiolite powder, and calcined kaolin.Plasticizers include: dioctyl terephthalate, polyvinyl alcohol, hydroxy silicone oil, and disproportionated rosin. The modified microspheres are prepared by the following process: mixing 2,2-dimethoxy-2-phenylacetophenone ethanol solution, methacrylic acid mono-capped polyethylene glycol aqueous solution, and methyl methacrylate, stirring the mixture under nitrogen protection, and performing ultraviolet irradiation, centrifugation and drying to obtain the modified microspheres.
Owner:安徽新翔包装材料有限公司

Exogenous ketone supplementation compositions, systems and methods

The claimed invention addresses the benefits of exogenous ketone supplementation in a subject in need thereof. In particular, the exogenous ketone supplementation includes the natural D-Beta HydroxyButyric acid, also described as natural D-BHB. As detailed in representative FIG. 1, natural D-BHB is preferentially consumed in the brain to glucose and additionally has a wide range of positive regulatory effects on the body and mind. Consumer applications for supplementation with natural D-BHB include improved sleep, anti-hunger, anti-anxiety, improved cognitive enhancement and athletic duration and post workout recovery through consumption of 10 grams or more of natural D-BHB. Therapeutic applications for exogenous natural D-BHB supplementation include anti-cancer, anti-kidney disease, anti-cognitive disorders and improved viral resistance through consumption of 10-20 grams or more of D-Beta HydroxyButyric acid.
Owner:KETONE CLARITY LLC

Application of beta hydroxybutyric acid in treatment of Parkinson disease

The invention provides an application of beta hydroxybutyric acid in treatment of the Parkinson disease. The application provided by the invention has the advantages that proved by in-vitro and in-vivo pharmacological experiments, the beta hydroxybutyric acid has the effects of reducing oxidative stress of dopaminergic neurons of a Parkinson's disease model, reducing the apoptosis of the dopaminergic neurons and reducing the damage of the dopaminergic neurons of substantia nigra of a PD animal model so as to play a role in treating the Parkinson disease.
Owner:XINXIANG MEDICAL UNIV

A method for high-density culture of prawns by using compound carbon source to regulate probiotic microbial flocs

ActiveCN106417124BReduce excessive oxygen demandSolve water quality control problemsClimate change adaptationPisciculture and aquariaBeta-Hydroxybutyric acidArginine
The invention relates to a method for intensive culture of prawn by utilizing beneficial microbial flocs regulated by composite carbons. The method is characterized by taking glucose, arginine, beta-hydroxybutyric acid, and poly-beta-hydroxybutyric acid as composite carbon sources, dividing the process of prawn culture into a microbial flocs system building stage, a nitrating function domestication stage and a system maintenance stage, and then applying different types of composite carbon sources in different quantity according to different proportion at different culture stage. The method has the advantages that since the industrial intensive prawn culture utilizing microbial flocs is divided into different stages, multiple carbon sources are utilized comprehensively to regulate functions of microorganisms at different stages, so that regulation and control of water quality in culture is solved intensively, benefiting effect of the bioflocculation technology is brought to full play, excessive requirement for oxygenation in the later period of culture is lowered, and a new effective, high-yield, water-saving, ecological and safe culture mode is achieved.
Owner:SHANGHAI OCEAN UNIV

Method for preparing test paper for rapidly determining dairy cows subclinical ketosis

The invention discloses a method for preparing a test paper for rapidly determining dairy cows subclinical ketosis, which comprises the following steps of: adding boric acid, aminoacetic acid and ethylene diamine tetraacetic acid solution in Arabic gum dissolved in a hot-water bath, adjusting the pH value of the prepared solution to be 7.0, soaking the test paper for 20 minutes in the prepared solution while the prepared solution is hot, drying the test paper in a drying oven at 60 DEG C, and standing the test paper in the drying oven overnight; and dissolving ethylene glycol, sodium nitroprusside and absolute ethyl alcohol in the hot-water bath, soaking the test paper for 20 minutes in the prepared solution while the prepared solution is hot, taking the test paper out, blotting moisture in the test paper by using filter paper, drying the test paper in the drying oven at 60 DEG C, and standing the test paper in the drying oven overnight so as to obtain the test paper. The reagent strip takes the concentration of beta-hydroxybutyric acid in blood more than 1.2mmol / L as a positive criteria; and the production practice proves that the reagent strip has the advantages of low cost, simple and easy operation, quick response, high specificity and high sensitivity, can be used for various determined samples such as blood, urine, serum, plasma and milk, and has wide application scope.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Blood ammonia determination reagent and preparation method thereof

The invention provides a blood ammonia determination reagent. The blood ammonia determination reagent comprises a buffer solution, a preservative and a stabilizing agent, and further comprises leucine dehydrogenase, alpha-ketonic acid NADH (Reduced Form of Nicotinamide-adenine Dinucleotid), beta-hydroxybutyric acid and beta-hydroxybutyrate dehydrogenase, wherein the enzyme activity unit ratio of beta-hydroxybutyrate dehydrogenase to leucine dehydrogenas is 1:10-2,000. According to the blood ammonia determination reagent provided by the invention, reduced coenzyme I(NADH) is oxidized into oxidized coenzyme I (NAD+) by applying a leucine dehydrogenase reaction system; the content of blood ammonia is directly reflected by determining the decrease rate of the reduced coenzyme I in the dominant wave of 340 nm. The sensitivity of the blood ammonia determination reagent can be ensured, and the stability of the NADH can also be ensured by adjusting the proportion of the beta-hydroxybutyrate dehydrogenase to the leucine dehydrogenase to be 1:10 to 2,000 through an experiment.
Owner:威海威高生物科技有限公司

Kit for detecting urinary lactic acid, creatine and beta-hydroxybutyric acid in human urine simultaneously

The invention provides a kit for detecting urinary lactic acid, creatine and beta-hydroxybutyric acid of human urine simultaneously, comprising a urine purification unit and a dry chemical reaction unit, wherein the urine purification unit is provided with a selective absorbent with combination of neutral alumina and activated carbon in weight ratio of 0.2-1:0.1-2, wherein the activated carbon is soaked by sodium hydroxide with concentration of 10-20%, and the selective absorbent is baked in a closed in a drying oven at the temperature of 70-250 DEG C for 4-72h; and the dry chemical reaction unit is a reaction box with a urinary lactic acid detection hole, a creatine detection hole and a beta-hydroxybutyric acid detection hole. The invention can detect concentration of urinary lactic acid, creatine and beta-hydroxybutyric acid of human urine simultaneously quickly and easily without help of other instruments and professional personnel so as to obtain qualitative or semiquantitative results.
Owner:北京中生金域诊断技术股份有限公司

Environment-friendly and biodegradable type plastics

The invention discloses environment-friendly and biodegradable type plastics. The environment-friendly and biodegradable type plastics comprises polylactic resin, modified polyvinyl-beta-hydroxybutyric acid PH B, diisononyl phthalate (DINP), tung oil based alkyd resin, soybean protein powder, oxidized cassava starch, alkaline clay, calcium carbonate, kapok fiber, linear low-density polyethylene grafted maleic anhydride, gamma-propyl glycidyl ether oxygen based trimethoxy silane, methyl methacrylate-butadiene-styrol copolymer, aluminum potassium sulfate, citrate, ethylene-eva ethylene, ethylene bis oleamide, methylene diphenyl diisocyanate, an antimycotic antibacterial agent, a degradation agent, antioxidant and a stabilizer. The plastics is good in tensile strength and breaking elongation, good in impact resistance, low in water absorption and good in light-transmitting quality, can be completely degraded into carbon dioxide and water after 132-136 days, and harm cannot be caused to the environment.
Owner:GUANGXI NANNING ZHICUI SCI TECH CONSULTATION CO LTD

Making process of medical fiber

The production method of medical fibre uses beta-hydroxybutyric acid and beta-hydroxyvaleric acid as raw material, and adopts the following steps: drying, melting, extruding, conveying, metering and spraying, cooling, solidifying and forming, drawing and setting to obtain the invented finished product. Said invented medical fibre possesses long degradation time, can be used for making operative suture and medical auxiliary material for curing wound hard to healing.
Owner:DONGHUA UNIV +1

Method for measuring beta-hydroxybutyric acid by using enzyme colorimetric reaction, matched kit and application thereof

The invention provides a method for measuring beta-hydroxybutyric acid by using enzyme colorimetric reaction, a matched kit and application thereof. Under the system of Tris-HCL buffer solution, serum beta-hydroxybutyric acid and coenzyme I are dehydrogenized under the catalysis of beta-hydroxybutyric acid dehydrogenase to generate acetoacetic acid and reduced coenzyme I, the generated reduced coenzyme I and iodonitrotetrazole chloride are reacted under the catalysis of diaphorase to generate a red substance formazane of which the highest absorbance is 505 nanometers, and then the content of the beta-hydroxybutyric acid in a biological sample is quantified by measuring the change of the absorbance of the red product at the wavelength of 505 nanometers. The method can linearly measure the concentration range (0 to 4.5 mmol / L) of the beta-hydroxybutyric acid in the biological sample, the measurement is used for judging the human ketosis for acid poisoning diagnosis, the reagent used by the method is liquid dual-reagent, and the quantity of the sample required for measuring the beta-hydroxybutyric acid is little; moreover, the reaction time during measuring is short, the operation is simple, and the method is suitable for mass detection.
Owner:NINGBO RUI BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products